When and Why do we need Glycosylation Analysis of Proteins?

12th July 2011

Category: Bioanalytical / Biosimilars

Tags: ,

By: Dr Daniel Galbraith, CSO

Most, if not all, biologics products start life with little or no “chemistry analysis” of the product. The biological (clinical) function of the molecule ruled supreme and was the most important factor. This is clearly changing as we now recognise the importance of the information provided by chemical analysis and we have the tools to perform More

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.